Literature DB >> 1592488

Effect of prostaglandin E1 on leukotriene C4-induced increases in vascular permeability of hamster cheek pouch.

T Yong1, W G Mayhan.   

Abstract

Our goal was to determine whether there is a synergistic effect of prostaglandin E1 (PGE1) on leukotriene C4 (LTC4)-induced increases in vascular permeability of the hamster cheek pouch in vivo. Changes in permeability were quantified by counting venular leaky sites (LS) and calculating clearance (CLR) of fluorescein isothiocyanate (FITC)-dextran 70kDa, during suffusion of the cheek pouch with LTC4 in the absence or presence of PGE1. LTC4 produced a dose-related increase in LS and CLR, and PGE1 (0.01 microM) significantly potentiated the effect of LTC4. During suffusion with LTC4 (15.0 nM) in the absence of PGE1, LS increased from 0 to 19 +/- 3/0.11 cm2 and CLR increased from 0.3 +/- 0.1 to 1.0 +/- 0.2 x 10(-6) ml/sec. During superfusion with LTC4 (15.0 nM) in the presence of PGE1, LS increased from 0 to 40 +/- 3/0.11 cm2, and CLR increased from 0.4 +/- 0.1 to 2.1 +/- 0.5 x 10(-6) ml/sec. To determine whether the effect of PGE1 on LTC4-induced increases in vascular permeability was related to the vasodilatory effect of PGE1, we examined the effect of isoproterenol (ISO). In contrast to that observed with PGE1, ISO decreased LTC4-induced increases in LS and CLR. Our data suggest that there is a synergistic effect of PGE1 on LTC4-induced increases in venular permeability that is not mediated by a vasodilatory action of PGE1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592488     DOI: 10.1007/bf00918955

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  19 in total

1.  Peripheral circulation: fluid transfer across the microvascular membrane.

Authors:  F J Haddy; J B Scott; G J Grega
Journal:  Int Rev Physiol       Date:  1976

Review 2.  Eicosanoids and inflammation.

Authors:  K I Williams; G A Higgs
Journal:  J Pathol       Date:  1988-10       Impact factor: 7.996

Review 3.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

4.  Prostaglandins as potentiators of increased vascular permeability in inflammation.

Authors:  T J Williams; J Morley
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

5.  Cooperative synthesis of leukotrienes by leukocytes and vascular cells.

Authors:  S J Feinmark
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 6.  Arachidonate metabolism in vascular disorders.

Authors:  P W Majerus
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

7.  The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin.

Authors:  M J Peck; P J Piper; T J Williams
Journal:  Prostaglandins       Date:  1981-02

8.  Simultaneous measurements of macromolecular leakage and arteriolar blood flow as altered by PGE1 and beta 2-receptor stimulant in the hamster cheek pouch.

Authors:  W L Joyner; E Svensjö; K E Arfors
Journal:  Microvasc Res       Date:  1979-11       Impact factor: 3.514

9.  The alterations of leukotriene C4 and prostaglandin E2 levels following different ischemic periods in rat brain tissue.

Authors:  S Aktan; C Aykut; S Oktay; B Yegen; E Keles; I Aykaç; S Ercan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1991-01       Impact factor: 4.006

10.  The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia).

Authors:  M G Johnston; J B Hay; H Z Movat
Journal:  Agents Actions       Date:  1976-11
View more
  2 in total

1.  Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin.

Authors:  W G Mayhan
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

2.  Effects of endothelin receptor antagonists on bradykinin-induced increases in macromolecular efflux.

Authors:  W G Mayhan; I Rubinstein
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.